OncoPEP oncopep.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

ONCoPEP is developing targeted immunotherapies to prevent the progression of cancer, prolong survival and restore the quality of life of patients. ONCoPEP's lead program, PVX-410, is a multi-peptide therapeutic cancer vaccine that is designed to target specific antigens found on the surface of multiple myeloma (MM) cancer cells. MM is a cancer of the plasma cells for which there is currently no cure.

ONCoPEP is developing targeted immunotherapies to prevent the progression of cancer, prolong survival and restore the quality of life of patients. ONCoPEP's lead program, PVX-410, is a multi-peptide therapeutic cancer vaccine that is designed to targ...Show all

Company (Alive / Active)

Phone: 978-688-2024

Fax:

520 Boston Street

North Andover, 01845
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
OncoPEP $11.1M Aug 28, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related OncoPEP Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)